Regal Assets Analytics

biotech

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

By |2019-03-25T11:45:49-04:00March 25th, 2019|Categories: Bill Langbein, Case Study, Education, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: , , , , |

One of the strongest performing biopharmaceutical stocks this year is [...]

Read More
 0

SanaCurrents Introduction – Turn to the Biotech Experts to Maximize Your Returns

By |2019-05-03T11:54:55-04:00November 4th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: , , , , , , |

Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious [...]

Read More
 0

Welcome to SanaCurrents

By |2018-12-04T12:07:49-05:00October 28th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , , , , , |

Life science investing always has been a roller coaster ride, [...]

Read More
 0
Go to Top